ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

DSP Nifty Healthcare ETF

DSP DSP Mutual Fund Feb 2024 — Sep 2026 31 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹17.05 CrAt NSE closes, Sep 2026
Companies held2020 with an NSE price
Top 10 holdings75.8%Of the equity shown here
Largest holding17.0%Sun Pharmaceutical Industries Limited
12-month turnover9.7%Estimated from 12 monthly disclosures · compare

Days to sell half: 0.0 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

31 priced months, Feb 2024 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

75.8% now, 76.7% in Sep 2025 · highest 82.9%, lowest 75.8%

Companies held

20 now, 20 in Sep 2025 · largest single holding 17.0% of equity

How it trades: no clear lean toward recent winners or losers (score +0.00 over 25 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Sector mix

Share of the equity shown · NSE industry

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. DSP Nifty Healthcare Index FundDSP · 20 shared100.0%
  2. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared100.0%
  3. Axis NIFTY Healthcare ETFAxis · 20 shared100.0%
  4. ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared99.9%
  5. EODWHFEdelweiss · 18 shared91.8%
  6. Nippon India Nifty Pharma ETFNippon India · 16 shared81.1%
  7. ICICI Prudential Nifty Pharma Index FundICICI Prudential · 16 shared81.1%
  8. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared79.8%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 2 Companies added
Complete exits 2 Companies sold out
Increases 0 More shares than last month
Reductions 18 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 17.00% 2.90 Cr 15,953 by Feb 2024 (31 mo+)
Divi's Laboratories Limited Healthcare Large Cap 10.44% 1.78 Cr 1,915 by Feb 2024 (31 mo+)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 7.43% 1.27 Cr 1,551 by Feb 2024 (31 mo+)
Laurus Labs Limited Healthcare Mid Cap 6.82% 1.16 Cr 5,868 by Feb 2024 (31 mo+)
Cipla Limited Healthcare Large Cap 6.70% 1.14 Cr 8,479 by Feb 2024 (31 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 6.65% 1.13 Cr 9,189 by Feb 2024 (31 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 6.24% 1.06 Cr 2,217 by Feb 2024 (31 mo+)
Max Healthcare Institute Limited Healthcare Large Cap 6.12% 1.04 Cr 11,213 by Feb 2024 (31 mo+)
Lupin Limited Healthcare Mid Cap 4.36% 0.74 Cr 3,660 by Feb 2024 (31 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 4.08% 0.70 Cr 4,164 by Feb 2024 (31 mo+)
Fortis Healthcare Limited Healthcare Mid Cap 3.55% 0.60 Cr 7,851 Mar 2025 (19 mo)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 3.11% 0.53 Cr 2,269 by Feb 2024 (31 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 2.75% 0.47 Cr 909 by Feb 2024 (31 mo+)
Zydus Lifesciences Limited Healthcare Mid Cap 2.55% 0.43 Cr 3,734 by Feb 2024 (31 mo+)
Mankind Pharma Limited Healthcare Mid Cap 2.51% 0.43 Cr 1,707 Mar 2025 (19 mo)
IPCA Laboratories Limited Healthcare Mid Cap 2.37% 0.40 Cr 2,093 by Feb 2024 (31 mo+)
Biocon Limited Healthcare Mid Cap 2.28% 0.39 Cr 10,501 by Feb 2024 (31 mo+)
Gland Pharma Limited Healthcare Small Cap 2.04% 0.35 Cr 1,201 Sep 2026 (1 mo)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 1.76% 0.30 Cr 4,021 Sep 2026 (1 mo)
Abbott India Limited Healthcare Mid Cap 1.26% 0.21 Cr 79 by Feb 2024 (31 mo+)

Half of its current holdings have been held for 31 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Piramal Pharma Limited Sep 2026 ▼ Complete exit -9,689
Krishna Institute of Medical Sciences Limited Sep 2026 ▲ New position +4,021
Syngene International Limited Sep 2026 ▼ Complete exit -2,960
Gland Pharma Limited Sep 2026 ▲ New position +1,201
Biocon Limited Sep 2026 ▼ Reducing -612
Sun Pharmaceutical Industries Limited Sep 2026 ▼ Reducing -543
Max Healthcare Institute Limited Sep 2026 ▼ Reducing -380
Dr. Reddy's Laboratories Limited Sep 2026 ▼ Reducing -306
Cipla Limited Sep 2026 ▼ Reducing -287
Fortis Healthcare Limited Sep 2026 ▼ Reducing -266
Laurus Labs Limited Sep 2026 ▼ Reducing -193
Zydus Lifesciences Limited Sep 2026 ▼ Reducing -162
Aurobindo Pharma Limited Sep 2026 ▼ Reducing -148
Lupin Limited Sep 2026 ▼ Reducing -123
Glenmark Pharmaceuticals Limited Sep 2026 ▼ Reducing -76
IPCA Laboratories Limited Sep 2026 ▼ Reducing -71
Torrent Pharmaceuticals Limited Sep 2026 ▼ Reducing -68
Divi's Laboratories Limited Sep 2026 ▼ Reducing -64
Mankind Pharma Limited Sep 2026 ▼ Reducing -56
Apollo Hospitals Enterprise Limited Sep 2026 ▼ Reducing -52
Abbott India Limited Sep 2026 ▼ Reducing -3
Alkem Laboratories Limited Sep 2026 ▼ Reducing -2
Sun Pharmaceutical Industries Limited Aug 2026 ▼ Reducing -156
Max Healthcare Institute Limited Aug 2026 ▼ Reducing -111
Biocon Limited Aug 2026 ▼ Reducing -106
Piramal Pharma Limited Aug 2026 ▼ Reducing -92
Dr. Reddy's Laboratories Limited Aug 2026 ▼ Reducing -91
Cipla Limited Aug 2026 ▼ Reducing -83
Fortis Healthcare Limited Aug 2026 ▼ Reducing -78
Laurus Labs Limited Aug 2026 ▼ Reducing -58
Aurobindo Pharma Limited Aug 2026 ▼ Reducing -41
Zydus Lifesciences Limited Aug 2026 ▼ Reducing -38
Lupin Limited Aug 2026 ▼ Reducing -36
Syngene International Limited Aug 2026 ▼ Reducing -29
Glenmark Pharmaceuticals Limited Aug 2026 ▼ Reducing -23
Torrent Pharmaceuticals Limited Aug 2026 ▼ Reducing -22
IPCA Laboratories Limited Aug 2026 ▼ Reducing -20
Divi's Laboratories Limited Aug 2026 ▼ Reducing -19
Mankind Pharma Limited Aug 2026 ▼ Reducing -17
Apollo Hospitals Enterprise Limited Aug 2026 ▼ Reducing -15
Alkem Laboratories Limited Aug 2026 ▼ Reducing -9
Torrent Pharmaceuticals Limited Jul 2026 ▲ Increasing +646
Sun Pharmaceutical Industries Limited Jul 2026 ▼ Reducing -111
Max Healthcare Institute Limited Jul 2026 ▼ Reducing -78
Biocon Limited Jul 2026 ▼ Reducing -75
Piramal Pharma Limited Jul 2026 ▼ Reducing -65
Dr. Reddy's Laboratories Limited Jul 2026 ▼ Reducing -64
Cipla Limited Jul 2026 ▼ Reducing -59
Fortis Healthcare Limited Jul 2026 ▼ Reducing -55
Laurus Labs Limited Jul 2026 ▼ Reducing -40
Aurobindo Pharma Limited Jul 2026 ▼ Reducing -29
Zydus Lifesciences Limited Jul 2026 ▼ Reducing -27
Lupin Limited Jul 2026 ▼ Reducing -25
Syngene International Limited Jul 2026 ▼ Reducing -21
Glenmark Pharmaceuticals Limited Jul 2026 ▼ Reducing -16
IPCA Laboratories Limited Jul 2026 ▼ Reducing -15
Divi's Laboratories Limited Jul 2026 ▼ Reducing -14
Mankind Pharma Limited Jul 2026 ▼ Reducing -12
Apollo Hospitals Enterprise Limited Jul 2026 ▼ Reducing -11
Alkem Laboratories Limited Jul 2026 ▼ Reducing -6
Sun Pharmaceutical Industries Limited Jun 2026 ▲ Increasing +1,518
Max Healthcare Institute Limited Jun 2026 ▲ Increasing +1,068
Biocon Limited Jun 2026 ▲ Increasing +1,017
Piramal Pharma Limited Jun 2026 ▲ Increasing +923
Dr. Reddy's Laboratories Limited Jun 2026 ▲ Increasing +876
Cipla Limited Jun 2026 ▲ Increasing +808
Fortis Healthcare Limited Jun 2026 ▲ Increasing +746
Laurus Labs Limited Jun 2026 ▲ Increasing +557
Zydus Lifesciences Limited Jun 2026 ▲ Increasing +358
Aurobindo Pharma Limited Jun 2026 ▲ Increasing +357
Lupin Limited Jun 2026 ▲ Increasing +352
Syngene International Limited Jun 2026 ▲ Increasing +276
Glenmark Pharmaceuticals Limited Jun 2026 ▲ Increasing +215
IPCA Laboratories Limited Jun 2026 ▲ Increasing +199
Divi's Laboratories Limited Jun 2026 ▲ Increasing +182
Mankind Pharma Limited Jun 2026 ▲ Increasing +162
Torrent Pharmaceuticals Limited Jun 2026 ▲ Increasing +155
Apollo Hospitals Enterprise Limited Jun 2026 ▲ Increasing +147
Alkem Laboratories Limited Jun 2026 ▲ Increasing +83
Abbott India Limited Jun 2026 ▲ Increasing +8
Sun Pharmaceutical Industries Limited May 2026 ▲ Increasing +948
Max Healthcare Institute Limited May 2026 ▲ Increasing +667
Biocon Limited May 2026 ▲ Increasing +637
Piramal Pharma Limited May 2026 ▲ Increasing +553
Dr. Reddy's Laboratories Limited May 2026 ▲ Increasing +545
Cipla Limited May 2026 ▲ Increasing +502
Fortis Healthcare Limited May 2026 ▲ Increasing +465
Laurus Labs Limited May 2026 ▲ Increasing +349
Aurobindo Pharma Limited May 2026 ▲ Increasing +249
Zydus Lifesciences Limited May 2026 ▲ Increasing +223
Lupin Limited May 2026 ▲ Increasing +216
Syngene International Limited May 2026 ▲ Increasing +168
Glenmark Pharmaceuticals Limited May 2026 ▲ Increasing +134
IPCA Laboratories Limited May 2026 ▲ Increasing +125
Divi's Laboratories Limited May 2026 ▲ Increasing +114
Mankind Pharma Limited May 2026 ▲ Increasing +101
Torrent Pharmaceuticals Limited May 2026 ▲ Increasing +93
Apollo Hospitals Enterprise Limited May 2026 ▲ Increasing +92
Alkem Laboratories Limited May 2026 ▲ Increasing +52
Abbott India Limited May 2026 ▲ Increasing +6

Changes compare consecutive month-end disclosures for this portfolio only.